Encompass Health - EHC Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" EHC shares.
View EHC analyst ratings or view top-rated stocks.

8 analysts have issued 12-month target prices for Encompass Health's stock. Their EHC share price forecasts range from $62.00 to $80.00. On average, they anticipate the company's share price to reach $66.89 in the next twelve months. This suggests a possible upside of 41.8% from the stock's current price.
View analysts price targets for EHC or view top-rated stocks among Wall Street analysts.

Encompass Health's stock was trading at $65.26 on January 1st, 2022. Since then, EHC stock has decreased by 27.7% and is now trading at $47.17.
View the best growth stocks for 2022 here.

Encompass Health saw a drop in short interest in August. As of August 31st, there was short interest totaling 2,840,000 shares, a drop of 32.7% from the August 15th total of 4,220,000 shares. Based on an average daily volume of 914,900 shares, the short-interest ratio is currently 3.1 days. Approximately 2.9% of the company's stock are sold short.
View Encompass Health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our EHC earnings forecast.

Encompass Health Co. (NYSE:EHC) posted its earnings results on Monday, August, 1st. The company reported $0.89 EPS for the quarter, missing the consensus estimate of $0.97 by $0.08. The business earned $1.33 billion during the quarter, compared to the consensus estimate of $1.34 billion. Encompass Health had a trailing twelve-month return on equity of 16.20% and a net margin of 6.22%. The company's revenue was up 3.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.17 earnings per share.

Encompass Health announced a quarterly dividend on Wednesday, July 20th. Shareholders of record on Monday, October 3rd will be given a dividend of $0.15 per share on Monday, October 17th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 1.27%. The ex-dividend date of this dividend is Friday, September 30th.
Read our dividend analysis for EHC.

Encompass Health (NYSE:EHC) pays an annual dividend of $1.12 per share and currently has a dividend yield of 2.35%. The dividend payout ratio is 34.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EHC will have a dividend payout ratio of 34.89% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EHC.

Encompass Health issued an update on its FY 2022 earnings guidance on Tuesday, August, 9th. The company provided earnings per share guidance of $2.77-$2.91 for the period, compared to the consensus earnings per share estimate of $3.96. The company issued revenue guidance of $4.25 billion-$4.30 billion, compared to the consensus revenue estimate of $5.38 billion.

231 employees have rated Encompass Health Chief Executive Officer Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Encompass Health's stock is owned by many different retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (3.03%), Baupost Group LLC MA (2.96%), State Street Corp (2.73%), Victory Capital Management Inc. (2.15%), Massachusetts Financial Services Co. MA (1.69%) and Glenview Capital Management LLC (1.38%). Insiders that own company stock include Andrew L Price, Donald L Correll, Elissa Joy Charbonneau, Kevin J O'connor, Mark J Tarr and Terrance Williams.
View institutional ownership trends.

Shares of EHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EHC stock can currently be purchased for approximately $47.17.

Encompass Health (NYSE:EHC) has a market capitalization of $4.71 billion and generates $5.12 billion in revenue each year. The company earns $412.20 million in net income (profit) each year or $3.27 on an earnings per share basis.

The company employs 43,400 workers across the globe.

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The official website for the company is www.healthsouth.com. The company can be reached via phone at (205) 967-7116, via email at investorrelations@healthsouth.com, or via fax at 205-969-4719.